Vascular Endothelial Growth Factor Receptor Inhibitor SU5416 Suppresses Lymphocyte Generation and Immune Responses in Mice by Increasing Plasma Corticosterone

Inhibitors of vascular endothelial growth factor and its receptors (VEGFRs) are attractive therapeutic candidates for cancer treatment. One such small molecule VEGFR inhibitor, SU5416, limits angiogenesis in vivo and is widely used for investigating VEGFR signaling in tumor pathophysiology. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grailer, Jamison J., Steeber, Douglas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774642/
https://www.ncbi.nlm.nih.gov/pubmed/24066177
http://dx.doi.org/10.1371/journal.pone.0075390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774642/
https://www.ncbi.nlm.nih.gov/pubmed/24066177
http://dx.doi.org/10.1371/journal.pone.0075390

Ejemplares similares